Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 4334-4342, September 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engbrecht, B. W.
Right arrow Articles by Fraker, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engbrecht, B. W.
Right arrow Articles by Fraker, D. L.
[Cancer Research 59, 4334-4342, September 1, 1999]
© 1999 American Association for Cancer Research


Experimental Therapeutics

Photofrin-mediated Photodynamic Therapy Induces Vascular Occlusion and Apoptosis in a Human Sarcoma Xenograft Model1

Brett W. Engbrecht2, Chandrakala Menon2, Alexander V. Kachur, Stephen M. Hahn and Douglas L. Fraker3

Harrison Department of Surgical Research [B. W. E., C. M., D. L. F.] and Department of Radiation Oncology [A. V. K., S. M. H.], School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104

Photodynamic therapy (PDT) involves light activation of a photosensitizer, resulting in oxygen-dependent, free radical-mediated cell death. Little is known about the efficacy of PDT in treating human sarcomas, despite an ongoing clinical trial treating i.p. sarcomatosis. The present study evaluates PDT treatment of a human sarcoma xenograft in nude mice and explores the mechanism of PDT-mediated antitumor effect. Athymic nude mice, 6–8 weeks of age, were s.c. injected with 5 x 106 cells of the A673 human sarcoma cell line. Tumors were allowed to grow to a diameter of about 10 mm. Photofrin (PF), 10 mg/kg, was injected by tail vein, and 24 h later, 630 nm light was delivered to the tumor with fluences of 50, 100, 150, or 300 J/cm2 at a fluence rate of 250 mW/cm2. To assess the efficacy of PDT in the treatment of sarcomas, photosensitizer uptake/retention studies and dose-response studies were performed. Studies carried out to determine the mechanism of tumor response included tumor temperature measurements before, during, and after treatment; tumor vascular perfusion studies with laser Doppler; electron microscopic analysis of tumor sections for vascular occlusion; and analysis of tumor cryosections for endothelial cell damage, apoptosis, and necrosis. At all time points of analysis, photosensitizer levels were greater in tumor than in muscle. Dose-response studies showed that at 100 J/cm2, five of six mice had a complete response to treatment, one of six had a partial response, and no deaths occurred. Temperature measurements indicated that thermal injury did not contribute to tumor response. Vascular perfusion studies demonstrated a significant reduction in blood flow as early as 6 h after PDT. Electron micrographs revealed erythrostasis in tumor microvessels starting as early as 2 h after treatment and complete occlusion of blood vessels by 12 h. Starting as early as 4 h after PDT, apoptosis first appeared in endothelial cells lining the occluded blood vessels and became more widespread at later time points. PDT is an effective treatment for this human sarcoma xenograft in nude mice. The mechanism of tumor destruction in this model appears to be vascular damage with initial apoptosis in tumor endothelial cells and delayed tumor cell apoptosis. This therapy may be valuable in the treatment of patients with sarcomatosis.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
S. Mitra, S. E. Cassar, D. J. Niles, J. A. Puskas, J. G. Frelinger, and T. H. Foster
Photodynamic therapy mediates the oxygen-independent activation of hypoxia-inducible factor 1{alpha}
Mol. Cancer Ther., December 1, 2006; 5(12): 3268 - 3274.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. M. Hahn, M. E. Putt, J. Metz, D. B. Shin, E. Rickter, C. Menon, D. Smith, E. Glatstein, D. L. Fraker, and T. M. Busch
Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy.
Clin. Cancer Res., September 15, 2006; 12(18): 5464 - 5470.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Solban, S. K. Pal, S. K. Alok, C. K. Sung, and T. Hasan
Mechanistic Investigation and Implications of Photodynamic Therapy Induction of Vascular Endothelial Growth Factor in Prostate Cancer
Cancer Res., June 1, 2006; 66(11): 5633 - 5640.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. W. Bauer, S. M. Hahn, F. R. Spitz, A. Kachur, E. Glatstein, and D. L. Fraker
Preliminary Report of Photodynamic Therapy for Intraperitoneal Sarcomatosis
Ann. Surg. Oncol., April 1, 2001; 8(3): 254 - 259.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. M. LaMuraglia, J. Schiereck, J. Heckenkamp, G. Nigri, P. Waterman, D. Leszczynski, and S. Kossodo
Photodynamic Therapy Induces Apoptosis in Intimal Hyperplastic Arteries
Am. J. Pathol., September 1, 2000; 157(3): 867 - 875.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.